We are delighted to announce that a further 102 institutions have joined our cost-neutral Read & Publish Open Access (OA) initiative since January 2023.
Over 700 institutions in 42 countries are now participating. We have agreements with thirteen library consortia, following new agreements with IISER, JULAC and ZB Med – Information Centre for Life Sciences as well as the renewal and expansion of our agreement with Electronic Information for Libraries (EIFL).
The success of our Read & Publish initiative is continuing to drive significant growth in the proportion of OA research content in our hybrid journals – Development, Journal of Cell Science and Journal of Experimental Biology – which were the first in the world to be afforded Transformative Journal status by Plan S.
We are also happy that libraries are increasingly choosing to take our 5-journal option to include our fully OA journals – Disease Models & Mechanisms and Biology Open – in their Read & Publish agreements.
Shelly Turner, Head of Sales and Business Development at The Company of Biologists, says:
Claire Moulton, Publisher, The Company of Biologists, says: